{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:09:01Z","timestamp":1790885341133,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41401-025-01614-7","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:44:22Z","timestamp":1754631862000},"page":"444-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dendritic cell-liposome conjugates reverse immunosuppressive tumor microenvironment for inhibiting colitis-associated colorectal cancer"],"prefix":"10.1038","volume":"47","author":[{"given":"Wen-zhe","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-di","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-wen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dang-ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"1614_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41586-024-07769-3","volume":"633","author":"L Nunes","year":"2024","unstructured":"Nunes L, Li F, Wu M, Luo T, Hammarstr\u00f6m K, Torell E, et al. Prognostic genome and transcriptome signatures in colorectal cancers. Nature. 2024;633:137\u201346.","journal-title":"Nature"},{"key":"1614_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20054-x","volume":"11","author":"O Levi-Galibov","year":"2020","unstructured":"Levi-Galibov O, Lavon H, Wassermann-Dozorets R, Pevsner-Fischer M, Mayer S, Wershof E, et al. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer. Nat Commun. 2020;11:6245.","journal-title":"Nat Commun"},{"key":"1614_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162:715\u201330.","journal-title":"Gastroenterology"},{"key":"1614_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","volume":"150","author":"AI Robles","year":"2016","unstructured":"Robles AI, Traverso G, Zhang M, Roberts NJ, Khan MA, Joseph C, et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology. 2016;150:931\u201343.","journal-title":"Gastroenterology"},{"key":"1614_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.4251\/wjgo.v15.i8.1317","volume":"15","author":"WY Dan","year":"2023","unstructured":"Dan WY, Zhou GZ, Peng LH, Pan F. Update and latest advances in mechanisms and management of colitis-associated colorectal cancer. World J Gastrointest Oncol. 2023;15:1317\u201331.","journal-title":"World J Gastrointest Oncol"},{"key":"1614_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653\u201367.","journal-title":"Nat Rev Immunol"},{"key":"1614_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/gutjnl-2018-316191","volume":"68","author":"AM Baker","year":"2019","unstructured":"Baker AM, Cross W, Curtius K, Al Bakir I, Choi CR, Davis HL, et al. Evolutionary history of human colitis-associated colorectal cancer. Gut. 2019;68:985\u201395.","journal-title":"Gut"},{"key":"1614_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7819824","volume":"2020","author":"DKW Ocansey","year":"2020","unstructured":"Ocansey DKW, Qiu W, Wang J, Yan Y, Qian H, Zhang X, et al. The achievements and challenges of mesenchymal stem cell-based therapy in inflammatory bowel disease and its associated colorectal cancer. Stem Cells Int. 2020;2020:7819824.","journal-title":"Stem Cells Int"},{"key":"1614_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00432-024-05755-w","volume":"150","author":"K Wang","year":"2024","unstructured":"Wang K, Wang Y, Yin K. Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies. J Cancer Res Clin Oncol. 2024;150:243.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1614_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/joim.12945","volume":"286","author":"AW Segal","year":"2019","unstructured":"Segal AW. Studies on patients establish Crohn\u2019s disease as a manifestation of impaired innate immunity. J Intern Med. 2019;286:373\u201388.","journal-title":"J Intern Med"},{"key":"1614_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fimmu.2017.00086","volume":"8","author":"LA Elliott","year":"2017","unstructured":"Elliott LA, Doherty GA, Sheahan K, Ryan EJ. Human tumor-infiltrating myeloid cells: phenotypic and functional diversity. Front Immunol. 2017;8:86.","journal-title":"Front Immunol"},{"key":"1614_CR12","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/s41388-022-02324-8","volume":"41","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang X, Xing Z, Lv S, Huang L, Liu J, et al. OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment. Oncogene. 2022;41:3131\u201350.","journal-title":"Oncogene"},{"key":"1614_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21:147\u201364.","journal-title":"Nat Rev Clin Oncol"},{"key":"1614_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113835","volume":"43","author":"Y Mei","year":"2024","unstructured":"Mei Y, Zhu Y, Yong KSM, Hanafi ZB, Gong H, Liu Y, et al. IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment. Cell Rep. 2024;43:113835.","journal-title":"Cell Rep"},{"key":"1614_CR15","doi-asserted-by":"publisher","first-page":"19242","DOI":"10.1021\/acsnano.3c05936","volume":"17","author":"S Li","year":"2023","unstructured":"Li S, Xu F, Ren X, Tan L, Fu C, Wu Q, et al. H2S-reactivating antitumor immune response after microwave thermal therapy for long-term tumor suppression. ACS Nano. 2023;17:19242\u201353.","journal-title":"ACS Nano"},{"key":"1614_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","volume":"32","author":"Y Xia","year":"2020","unstructured":"Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for cancer immunotherapy and drug delivery. Adv Mater. 2020;32:2002054.","journal-title":"Adv Mater"},{"key":"1614_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell. 2021;184:792\u2013809.","journal-title":"Cell"},{"key":"1614_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O\u2019Brien SA, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181:442\u201359.","journal-title":"Cell"},{"key":"1614_CR19","doi-asserted-by":"publisher","first-page":"e73666","DOI":"10.1371\/journal.pone.0073666","volume":"8","author":"CX Xiao","year":"2013","unstructured":"Xiao CX, Wang HH, Shi Y, Li P, Liu YP, Ren JL, et al. Distribution of bone-marrow-derived endothelial and immune cells in a murine colitis-associated colorectal cancer model. PLoS One. 2013;8:e73666.","journal-title":"PLoS One"},{"key":"1614_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41575-022-00663-1","volume":"20","author":"S Zundler","year":"2023","unstructured":"Zundler S, G\u00fcnther C, Kremer AE, Zaiss MM, Rothhammer V, Neurath MF. Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation. Nat Rev Gastroenterol Hepatol. 2023;20:50\u201364.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1614_CR21","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.4049\/jimmunol.1402166","volume":"194","author":"M Herov\u00e1","year":"2015","unstructured":"Herov\u00e1 M, Schmid M, Gemperle C, Hersberger M. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J Immunol. 2015;194:2330\u20137.","journal-title":"J Immunol"},{"key":"1614_CR22","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1182\/blood-2010-11-321752","volume":"117","author":"P Sinha","year":"2011","unstructured":"Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood. 2011;117:5381\u201390.","journal-title":"Blood"},{"key":"1614_CR23","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1074\/jbc.M109.044131","volume":"285","author":"T Ohira","year":"2010","unstructured":"Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke TE, Serhan CN. Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem. 2010;285:3451\u201361.","journal-title":"J Biol Chem"},{"key":"1614_CR24","doi-asserted-by":"publisher","first-page":"abl5420","DOI":"10.1126\/sciadv.abl5420","volume":"8","author":"R De Matteis","year":"2022","unstructured":"De Matteis R, Flak MB, Gonzalez-Nunez M, Austin-Williams S, Palmas F, Colas RA, et al. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Sci Adv. 2022;8:abl5420.","journal-title":"Sci Adv"},{"key":"1614_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41551-023-01031-3","volume":"7","author":"LJ Dooling","year":"2023","unstructured":"Dooling LJ, Andrechak JC, Hayes BH, Kadu S, Zhang W, Pan R, et al. Cooperative phagocytosis of solid tumours by macrophages triggers durable anti-tumour responses. Nat Biomed Eng. 2023;7:1081\u201396.","journal-title":"Nat Biomed Eng"},{"key":"1614_CR26","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1158\/0008-5472.CAN-17-3962","volume":"78","author":"G Yan","year":"2018","unstructured":"Yan G, Zhao H, Zhang Q, Zhou Y, Wu L, Lei J, et al. A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis. Cancer Res. 2018;78:5586\u201399.","journal-title":"Cancer Res"},{"key":"1614_CR27","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.3390\/ijms21093062","volume":"21","author":"T Hirano","year":"2020","unstructured":"Hirano T, Hirayama D, Wagatsuma K, Yamakawa T, Yokoyama Y, Nakase H. Immunological mechanisms in inflammation-associated colon carcinogenesis. Int J Mol Sci. 2020;21:3062.","journal-title":"Int J Mol Sci"},{"key":"1614_CR28","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8:328rv4.","journal-title":"Sci Transl Med"},{"key":"1614_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651\u201368.","journal-title":"Nat Rev Immunol"},{"key":"1614_CR30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.12998\/wjcc.v7.i4.405","volume":"7","author":"A Som","year":"2019","unstructured":"Som A, Mandaliya R, Alsaadi D, Farshidpour M, Charabaty A, Malhotra N, et al. Immune checkpoint inhibitor-induced colitis: A comprehensive review. World J Clin Cases. 2019;7:405\u201318.","journal-title":"World J Clin Cases"},{"key":"1614_CR31","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.12998\/wjcc.v12.i6.1050","volume":"12","author":"T Velikova","year":"2024","unstructured":"Velikova T, Krastev B, Gulinac M, Zashev M, Graklanov V, Peruhova M. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitis. World J Clin Cases. 2024;12:1050\u201362.","journal-title":"World J Clin Cases"},{"key":"1614_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.adh8342","volume":"383","author":"BC Lo","year":"2024","unstructured":"Lo BC, Kryczek I, Yu J, Vatan L, Caruso R, Matsumoto M, et al. Microbiota-dependent activation of CD4+ T cells induces CTLA-4 blockade-associated colitis via Fc\u03b3 receptors. Science. 2024;383:62\u201370.","journal-title":"Science"},{"key":"1614_CR33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","volume":"40","author":"Y Hailemichael","year":"2022","unstructured":"Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell. 2022;40:509\u201323.","journal-title":"Cancer Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01614-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:06:26Z","timestamp":1768572386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01614-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1614"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01614-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}